Promacta 75 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJQ03
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,059
Award facts
- Contract value 100% obligated
- $24,059.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,059.26 to AmerisourceBergen Drug Corp for PROMACTA 75 mg tablets (30-count packaging) on August 25, 2025, with a completion date of September 16, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems, and this contract demonstrates its role as a critical supplier of brand-name and generic medications to support military medical supply requirements.
This delivery order is executed under AmerisourceBergen's prime indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and active through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply various medications and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. PROMACTA (eltrombopag) is a thrombopoietin receptor agonist used in hematologic treatment, reflecting the breadth of specialty pharmaceutical products available through AmerisourceBergen's DLA contract vehicle for federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DB25FJQ03?
SPE2DB25FJQ03 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FJQ03 worth?
The government has obligated $24,059 on SPE2DB25FJQ03.
Is contract SPE2DB25FJQ03 an order under another contract?
Yes. SPE2DB25FJQ03 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJQ03 competed?
The extent of competition for SPE2DB25FJQ03 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award